[en] Inflammatory bowel diseases are chronic diseases whose long-term evolution depends on the depth of remission. Their clinical and endoscopic evaluation is imperfect. The development of confocal endomicroscopy allows microscopic images to be obtained in vivo. These microscopic data are correlated with the activity of the disease. They predict a possible relapse of the disease and also predict the response to treatment with a biological agent, which allows to modify the therapy before the relapse or to make a rational choice between the different biological agents before introducing a new treatment.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
LOLY, Jean-Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Service de gastroentérologie, hépatologie, onco. digestive
SOMJA, Joan ; Centre Hospitalier Universitaire de Liège - CHU > Service dermatopathologie
REENAERS, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Service de gastroentérologie, hépatologie, onco. digestive
VAN KEMSEKE, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Service de gastroentérologie, hépatologie, onco. digestive
GAST, Pierrette ; Centre Hospitalier Universitaire de Liège - CHU > Service de gastroentérologie, hépatologie, onco. digestive
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Language :
French
Title :
Endomicroscopie confocale dans la prise en charge des maladies inflammatoires chroniques de l'intestin.
Alternative titles :
[en] Interest of confocal endomicroscopy for the management of chronic inflammatory bowel disease
Lichtenstein GR. Emerging prognostic markers to determine Crohns disease natural history and improve management strategies: A review of recent literature. Gastroenterol Hepatol 2010;6:99-107.
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease : rePort of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl. A):5A-36A.
Pariente B, Cosnes J, Danese S, et al. Development of the Crohns disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011;17:1415-22.
Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE) : Determining therapeutic goals for treat-To-Target. Am J Gastroenterol 2015;110:1324-38.
Bryant RV, Burger DC, Delo J, et al. Beyond endoscopic mucosal healing in UC : Histological remission better predicts corticosteroid use and hospitalisation over 6 years of followup. Gut 2016;65:408-14.
Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohns disease. Gastroenterology 2010;138:463-8.
Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-Term outcome of maintenance therapy with infliximab in Crohns disease. Inflamm Bowel Dis 2009;15:1295-301.
Meunier P, Cousin F, Van Kemseke C, et al. Persisting signs of disease activity at magnetic resonance enterocolonography predict clinical relapse and disease progression in quiescent Crohns disease. Acta Gastro-Enterol Belg 2015;78:274-81.
Karstensen JG, Saftoiu A, Brynskov J, et al. Confocal laser endomicroscopy in ulcerative colitis : A longitudinal study of endomicroscopic changes and response to medical therapy (with videos). Gastrointest Endosc 2016;84:279-86.e1.
Neumann H, Vieth M, Atreya R, et al. Assessment of Crohns disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis 2012;18:2261-9.
Kiesslich R, Goetz M, Neurath MF. Confocal laser endomicroscopy for gastrointestinal diseases. Gastrointest Endosc Clin N Am 2008;18:451-66, viii.
Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012;61:1146-53.
Moussata D, Goetz M, Gloeckner A, et al. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut 2011;60:26-33.
Rasmussen DN, Karstensen JG, Riis LB, Brynskov J, Vilmann P. Confocal laser endomicroscopy in inflammatory bowel disease : A systematic review. J Crohns Colitis 2015;9:1152-9.
Li C-Q, Liu J, Ji R, Li Z, Xie X-J, Li Y-Q. Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis. BMC Gastroenterol 2014;14:45.
Liu JJ, Kay TM, Davis EM, et al. Epithelial cell extrusion zones observed on confocal laser endomicroscopy correlates with immunohistochemical staining of mucosal biopsy samples. Dig Dis Sci 2016;61:1895-902.
Chang J, Leong RW, Wasinger V, et al. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. Gastroenterology 2017; epub ahead of print.
Buda A, Hatem G, Neumann H, et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis : A pilot study. J Crohns Colitis 2014;8:304-11.
Atreya R, Neumann H, Neufert C, et al. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohns disease. Nat Med 2014;20:313-8.